IP Library Granted Patent US 10,052,487
Granted Patent B2
US 10,052,487 · App. 13/588,808 · Granted Aug 21, 2018

Methods and devices for adapting charge initiation for an implantable defibrillator

Inventors: Jay A. Warren (San Juan Capistrano, CA); Gust H. Bardy (Carnation, WA)
Assignee: Cameron Health, Inc.
A61N1/3621A61N1/3943A61N1/3956
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,052,487
App. No.
13/588,808
Granted
Aug 21, 2018
Kind
B2
Abstract

Adaptive methods for initiating charging of the high power capacitors of an implantable medical device for therapy delivery after the patient experiences a non-sustained arrhythmia, and devices that perform such methods. The adaptive methods and devices adjust persistence criteria used to analyze an arrhythmia prior to initiating a charging sequence to deliver therapy. Some embodiments apply a specific sequence of X-out-of-Y criteria, persistence criteria, and last event criteria before starting charging for therapy delivery.

Claims (41)

1. A method of avoiding inappropriate therapy delivery to a patient in an implantable defibrillator, the implantable defibrillator comprising a number of implantable electrodes and operational circuitry for performing cardiac signal analysis and therapy delivery using the implantable electrodes, the method comprising, at a first time:

detecting cardiac events in a patient using the implantable electrodes;

filling an X-out-of-Y filter with data related to the detected cardiac events and using the X-out-of-Y filter to determine that X exceeds a predetermined treatment threshold;

when X exceeds the predetermined treatment threshold, using a predetermined persistence threshold, N, and applying a persistence rule calling for X to exceed the predetermined treatment threshold for at least N consecutive cardiac events;

when the persistence rule is met, initiating a charging sequence to charge a capacitor for therapy delivery;

after initiating the charging sequence but before therapy delivery, determining that the cardiac signal data of the patient no longer indicates a need for therapy; and

upon determining, after initiating the charging sequence but before therapy delivery, that the cardiac signal data of the patient no longer indicates a need for therapy, modifying N to increase the quantity of consecutive cardiac events required to meet the persistence threshold and storing N for use in the future; and

the method further comprising, at a second time:

detecting cardiac events in the patient using the implantable electrodes;

filling the X-out-of-Y filter with data related to the detected cardiac events and using the X-out-of-Y filter to determine that X exceeds a predetermined treatment threshold;

when X exceeds the predetermined treatment threshold, applying the persistence rule calling for X to exceed the predetermined treatment threshold for at least N consecutive cardiac events, wherein N, when applied at the second time, is modified in view of the occurrence of the first time; and

finding that the persistence rule is not met due to the increase in N at least once.

2. The method of claim 1 wherein the X-out-of-Y filter is filled by increasing X when a detected cardiac event, when analyzed by the operational circuitry, is found to exceed a rate threshold.

3. The method of claim 1 wherein the X-out-of-Y filter is filled by increasing X when a detected event, when analyzed by the operational circuitry, meets one of the two following criteria:

the detected event indicates a rate that exceeds a fast rate threshold; or

the detected event indicates a rate below the fast rate threshold but above a low rate threshold and meets detection enhancement criteria that indicate a malignant arrhythmia.

4. The method of claim 1 wherein at least one of the electrodes is disposed on a lead that is emplaced transvenously in the patient.

5. The method of claim 1 wherein all of the electrodes are disposed subcutaneously in the patient without entering the heart or contacting cardiac tissue.

6. The method of claim 1 wherein the X-out-of-Y filter is applied by using an 18-out-of-24 rule as the predetermined treatment threshold.

7. The method of claim 1 further comprising, after finding that the persistence rule is not met due to the increase in N at least once, detecting at least one cardiac event and finding that the persistence rule is met using the increased N, and initiating the charging sequence a second time.

8. The method of claim 7 further comprising, after initiating the charging sequence a second time, delivering therapy to the patient.

9. An implantable defibrillator comprising a number of implantable electrodes and operational circuitry for performing cardiac signal analysis and therapy delivery using the implantable electrodes, the operational circuitry being configured to perform the following:

at a first time:

detecting cardiac events in a patient using the implantable electrodes;

filling an X-out-of-Y filter with data related to the detected cardiac events and using the X-out-of-Y filter to determine that X exceeds a predetermined treatment threshold;

when X exceeds the predetermined treatment threshold, using a predetermined persistence threshold, N, and applying a persistence rule calling for X to exceed the predetermined treatment threshold for at least N consecutive cardiac events;

when the persistence rule is met, initiating a charging sequence to charge a capacitor for therapy delivery;

after initiating the charging sequence but before therapy delivery, determining that the cardiac signal data of the patient no longer indicates a need for therapy; and

upon determining, after initiating the charging sequence but before therapy delivery, that the cardiac signal data of the patient no longer indicates a need for therapy, modifying N to increase the quantity of consecutive cardiac events required to meet the persistence threshold and storing N for use in the future; and

at a second time:

detecting cardiac events in the patient using the implantable electrodes;

filling the X-out-of-Y filter with data related to the detected cardiac events and using the X-out-of-Y filter to determine that X exceeds a predetermined treatment threshold;

when X exceeds the predetermined treatment threshold, applying the persistence rule calling for X to exceed the predetermined treatment threshold for at least N consecutive cardiac events, wherein N, when applied at the second time, is modified in view of the occurrence of the first time; and

finding that the persistence rule is not met due to the increase in N at least once.

10. The implantable defibrillator of claim 9 wherein the operational circuitry is further configured such that the X-out-of-Y filter is filled by increasing X when a detected cardiac event, when analyzed by the operational circuitry, is found to exceed a rate threshold.

11. The implantable defibrillator of claim 9 wherein the operational circuitry is further configured such that the X-out-of-Y filter is filled by increasing X when a detected event, when analyzed by the operational circuitry, meets one of the two following criteria:

the detected event indicates a rate that exceeds a fast rate threshold; or

the detected event indicates a rate below the fast rate threshold but above a low rate threshold and meets detection enhancement criteria that indicate a malignant arrhythmia.

12. The implantable defibrillator of claim 9 wherein the operational circuitry is configured to apply the X-out-of-Y filter by using an 18-out-of-24 rule as the predetermined treatment threshold.

13. The implantable defibrillator of claim 9 wherein the operational circuitry is configured to detect at least one cardiac event and find that the persistence rule is met after finding that the persistence rule is not met due to the increase in N at least once, and in response to finding that the persistence rule is met using the increased N, initiate the charging sequence a second time.

14. The implantable defibrillator of claim 13 further comprising, after initiating the charging sequence a second time, delivering therapy to the patient.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 23, 2012
From: WARREN, JAY A.; BARDY, GUST H.
To: CAMERON HEALTH, INC.
Reel/Frame 029523/0996 →
Continuity (3)
Continuation 12359072 · Jan 23, 2009
Continuation 11042911 · Jan 25, 2005
Related Publication 20120316612A1 · Dec 13, 2012